{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T17:40:09Z","timestamp":1780508409466,"version":"3.54.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008247","name":"University of Otago","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008247","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Prostate cancer treatment can lead to significant long-term side effects that impact patients\u2019 quality of life and supportive care needs (SCN). This study explores the associations between quality of life (QoL) and SCN among prostate cancer survivors, with a focus on the impact of treatment received, care service utilization, and the differences between M\u0101ori and non-M\u0101ori patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Random stratified sampling data were collected from 1075 prostate cancer survivors who were diagnosed within the past 5\u00a0years. Hierarchical regression analyses examined the associations between QoL domains and SCN, adjusting for demographic, clinical, and treatment-related factors. LASSO (Least Absolute Shrinkage and Selection Operator) was used to select variables to test the interaction effects of different treatments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Significant disparities were found between M\u0101ori and non-M\u0101ori patients in physical and mental health scores, care service utilization, and overall SCN. M\u0101ori men had lower scores in these areas. Most QoL domains were negatively associated with more SCN, particularly mental health and hormonal issues. Androgen deprivation therapy (ADT) exacerbates some negative effects of poor mental health and hormonal issues for non-M\u0101ori, while the use of care services and radical prostatectomy (RP) was associated with mitigating SCN for M\u0101ori patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study highlights the complex interplay between QoL, SCN, and treatment modalities among prostate cancer survivors in New Zealand. The findings underscore the need for culturally tailored supportive care services to address the unique needs of M\u0101ori patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00520-025-09521-7","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T15:34:23Z","timestamp":1747755263000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Quality of life and supportive care needs in prostate cancer: the impact of treatment received and care service utilization among M\u0101ori and non-M\u0101ori patients in New Zealand"],"prefix":"10.1007","volume":"33","author":[{"given":"Hui","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. David","family":"Baxter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhou","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Hoeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Wibowo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"issue":"6","key":"9521_CR1","doi-asserted-by":"publisher","first-page":"367.e19","DOI":"10.1016\/j.urolonc.2021.02.023","volume":"39","author":"B Matti","year":"2021","unstructured":"Matti B, Zargar-Shoshtari K (2021) Prostate cancer outcomes disparities: population survival analysis in an ethnically diverse nation. Urol Oncol: Seminars Original Investigations 39(6):367.e19-367.e26","journal-title":"Urol Oncol: Semin Original Inv"},{"key":"9521_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/tre.484","volume":"6","author":"E Wibowo","year":"2015","unstructured":"Wibowo E, Schellhammer PF, Montie JE, Lange PH, Goldenberg SL, Wassersug RJ (2015) \u2018Should I get a PSA test?\u2019 \u2013 the question is not that simple. Trends in Urology & Men\u2019s Health 6:31\u201334","journal-title":"Trends Urol Men's Health"},{"issue":"1521","key":"9521_CR3","first-page":"69","volume":"133","author":"R Egan","year":"2020","unstructured":"Egan R, Lawrenson R, Kidd J, Cassim S, Black S, Blundell R, Bateman J, Broughton JR (2020) Inequalities between M\u0101ori and non-M\u0101ori men with prostate cancer in Aotearoa New Zealand. NZ Med J 133(1521):69\u201376","journal-title":"NZ Med J"},{"issue":"2","key":"9521_CR4","doi-asserted-by":"publisher","first-page":"e70110","DOI":"10.1002\/pon.70110","volume":"34","author":"H Xiao","year":"2025","unstructured":"Xiao H, Baxter GD, Liu L, Hoeta T, Wibowo E (2025) The landscape of supportive care needs among prostate cancer patients in New Zealand: a cross-ethnic analysis. Psychooncology 34(2):e70110. https:\/\/doi.org\/10.1002\/pon.70110","journal-title":"Psychooncology"},{"issue":"4","key":"9521_CR5","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.socscimed.2006.01.027","volume":"63","author":"IJ Korfage","year":"2006","unstructured":"Korfage IJ, Hak T, de Koning HJ, Essink-Bot M-L (2006) Patients\u2019 perceptions of the side-effects of prostate cancer treatment -a qualitative interview study. Soc Sci Med 63(4):911\u2013919","journal-title":"Soc Sci Med"},{"issue":"5","key":"9521_CR6","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1016\/S0022-5347(05)65679-0","volume":"166","author":"CG Bacon","year":"2001","unstructured":"Bacon CG, Giovannucci E, Testa M, Kawachi I (2001) The impact of cancer treatment on quality of life outcomes for patients with localized prostate cancer. J Urol 166(5):1804\u20131810","journal-title":"J Urol"},{"issue":"2","key":"9521_CR7","doi-asserted-by":"publisher","first-page":"e13541","DOI":"10.1111\/ecc.13541","volume":"31","author":"J Prashar","year":"2022","unstructured":"Prashar J, Schartau P, Murray E (2022) Supportive care needs of men with prostate cancer: a systematic review update. Eur J Cancer Care 31(2):e13541","journal-title":"Eur J Cancer Care"},{"issue":"8","key":"9521_CR8","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1038\/bjc.2013.568","volume":"109","author":"J Cockle-Hearne","year":"2013","unstructured":"Cockle-Hearne J, Charnay-Sonnek F, Denis L, Fairbanks H, Kelly D, Kav S et al (2013) The impact of supportive nursing care on the needs of men with prostate cancer: a study across seven European countries. Br J Cancer 109(8):2121\u20132130","journal-title":"Br J Cancer"},{"key":"9521_CR9","unstructured":"Ministry of Health NZ (2018) Evaluation of the cancer psychological and social support initiative: interim reports one and two sapere research group.https:\/\/www.health.govt.nz\/publication\/interim-report-one-and-two-evaluation-cancer-psychological-and-social-support-initiative"},{"issue":"1","key":"9521_CR10","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1186\/s12913-023-09580-8","volume":"23","author":"J Bateman","year":"2023","unstructured":"Bateman J, Egan R, Maclennan K (2023) \u2018Survivorship care is one big gap\u2019: a qualitative study of post-treatment supportive care in Aotearoa New Zealand. BMC Health Serv Res 23(1):594","journal-title":"BMC Health Serv Res"},{"issue":"2","key":"9521_CR11","first-page":"e12975","volume":"28","author":"J Kidd","year":"2019","unstructured":"Kidd J, Raphael D, Cassim S, Black S, Blundell R, Egan R (2019) Health service provider responses to indigenous peoples with cancer: an integrative review. Eur J Cancer Care 28(2):e12975","journal-title":"Eur J Cancer Care"},{"key":"9521_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/bju.12900","volume":"115","author":"Z Obertov\u00e1","year":"2015","unstructured":"Obertov\u00e1 Z, Scott N, Brown C, Stewart A, Lawrenson R (2015) Survival disparities between M\u0101ori and non-M\u0101ori men with prostate cancer in New Zealand. Br J Urol 115:24\u201330","journal-title":"Br J Urol"},{"key":"9521_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12904-018-0381-6","volume":"17","author":"M Holm","year":"2018","unstructured":"Holm M, Doveson S, Lindqvist O, Wennman-Larsen A, Fransson P (2018) Quality of life in men with metastatic prostate cancer in their final years before death\u2013a retrospective analysis of prospective data. BMC Palliat Care 17:1\u20138","journal-title":"BMC Palliat Care"},{"key":"9521_CR14","unstructured":"Centre for Men's Health NZ. Supportive care needs in prostate cancer (SUPPRO) research study 2023 [retrieved 2024 April, cited 2024 May 6]. Available from:  https:\/\/www.otago.ac.nz\/mens-health\/research\/supportive-care-needs-in-prostate-cancer-suppro-research-study"},{"issue":"4","key":"9521_CR15","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1111\/j.1365-2753.2008.01057.x","volume":"15","author":"A Boyes","year":"2009","unstructured":"Boyes A, Girgis A, Lecathelinais C (2009) Brief assessment of adult cancer patients\u2019 perceived needs: development and validation of the 34-item Supportive Care Needs Survey (SCNS-SF34). J Eval Clin Pract 15(4):602\u2013606. https:\/\/doi.org\/10.1111\/j.1365-2753.2008.01057.x","journal-title":"J Eval Clin Pract"},{"key":"9521_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-12-300","volume":"12","author":"G Garvey","year":"2012","unstructured":"Garvey G, Beesley VL, Janda M, Jacka C, Green AC, O\u2019Rourke P, Valery PC (2012) The development of a supportive care needs assessment tool for Indigenous people with cancer. BMC Cancer 12:1","journal-title":"BMC Cancer"},{"key":"9521_CR17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.urology.2019.02.004","volume":"127","author":"DJ Einstein","year":"2019","unstructured":"Einstein DJ, Patil D, Chipman J, Regan MM, Davis K, Crociani CM, Wagner AA, Sanda MG, Chang P (2019) Expanded Prostate Cancer Index Composite-26 (EPIC-26) online: validation of an internet-based instrument for assessment of health-related quality of life after treatment for localized prostate Cancer. Urology 127:53\u201360","journal-title":"Urology"},{"issue":"5","key":"9521_CR18","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/ecc.12286","volume":"24","author":"AJL King","year":"2015","unstructured":"King AJL, Evans M, Moore THM et al (2015) Prostate cancer and supportive care: a systematic review and qualitative synthesis of men\u2019s experiences and unmet needs. Eur J Cancer Care (Engl) 24(5):618\u2013634. https:\/\/doi.org\/10.1111\/ecc.12286","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"12","key":"9521_CR19","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1038\/sj.bjc.6604406","volume":"98","author":"E Ream","year":"2008","unstructured":"Ream E, Quennell A, Fincham L, Faithfull S, Khoo V, Wilson-Barnett J et al (2008) Supportive care needs of men living with prostate cancer in England: a survey. Br J Cancer 98(12):1903\u20131909","journal-title":"Br J Cancer"},{"issue":"2","key":"9521_CR20","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/ecc.12468","volume":"25","author":"C Lao","year":"2016","unstructured":"Lao C, Obertov\u00e1 Z, Brown C, Scott N, Edlin R, Gilling P et al (2016) Differences in survival between M\u0101ori and New Zealand Europeans with prostate cancer. Eur J Cancer Care 25(2):262\u2013268","journal-title":"Eur J Cancer Care"},{"issue":"2","key":"9521_CR21","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.urology.2014.04.036","volume":"84","author":"KM Davis","year":"2014","unstructured":"Davis KM, Kelly SP, Luta G, Tomko C, Miller AB, Taylor KL (2014) The association of long-term treatment-related side effects with cancer-specific and general quality of life among prostate cancer survivors. Urology 84(2):300\u2013306","journal-title":"Urology"},{"issue":"10","key":"9521_CR22","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1002\/pon.3882","volume":"24","author":"DA Galv\u00e3o","year":"2015","unstructured":"Galv\u00e3o DA, Newton RU, Gardiner RA, Girgis A, Lepore SJ, Stiller A et al (2015) Compliance to exercise-oncology guidelines in prostate cancer survivors and associations with psychological distress, unmet supportive care needs, and quality of life. Psychooncology 24(10):1241\u20131249","journal-title":"Psychooncology"},{"key":"9521_CR23","doi-asserted-by":"crossref","unstructured":"Korfage IJ, Essink-Bot ML, Janssens AC, Schr\u00f6der FH, De Koning HJ (2006) Anxiety and depression after prostate cancer diagnosis and treatment: 5-year follow-up. Br J Cancer 94(8):1093\u20138","DOI":"10.1038\/sj.bjc.6603057"},{"key":"9521_CR24","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1007\/s10147-014-0781-4","volume":"20","author":"Z Obertov\u00e1","year":"2015","unstructured":"Obertov\u00e1 Z, Lawrenson R, Scott N et al (2015) Treatment modalities for M\u0101ori and New Zealand European men with localised prostate cancer. Int J Clin Oncol 20:814\u2013820. https:\/\/doi.org\/10.1007\/s10147-014-0781-4","journal-title":"Int J Clin Oncol"},{"issue":"6B","key":"9521_CR25","doi-asserted-by":"publisher","first-page":"E36","DOI":"10.1111\/bju.13179","volume":"117","author":"S Carlsson","year":"2016","unstructured":"Carlsson S, Drevin L, Loeb S, Widmark A, Lissbrant IF, Robinson D et al (2016) Population-based study of long-term functional outcomes after prostate cancer treatment. BJU Int 117(6B):E36\u2013E45","journal-title":"BJU Int"},{"key":"9521_CR26","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.urology.2017.01.030","volume":"104","author":"PS Kirk","year":"2017","unstructured":"Kirk PS, Govani S, Borza T, Hollenbeck BK, Davis J, Shumway D et al (2017) Implications of prostate cancer treatment in men with inflammatory bowel disease. Urology 104:131\u2013136","journal-title":"Urology"},{"issue":"16","key":"9521_CR27","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1200\/JCO.2015.64.1969","volume":"34","author":"KT Dinh","year":"2016","unstructured":"Dinh KT, Reznor G, Muralidhar V, Mahal BA, Nezolosky MD, Choueiri TK et al (2016) Association of androgen deprivation therapy with depression in localized prostate cancer. J Clin Oncol 34(16):1905","journal-title":"J Clin Oncol"},{"issue":"10","key":"9521_CR28","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/iju.13409","volume":"24","author":"KT Dinh","year":"2017","unstructured":"Dinh KT, Yang DD, Nead KT, Reznor G, Trinh QD, Nguyen PL (2017) Association between androgen deprivation therapy and anxiety among 78 000 patients with localized prostate cancer. Int J Urol 24(10):743\u2013748","journal-title":"Int J Urol"},{"issue":"1","key":"9521_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/aje\/kwv307","volume":"184","author":"AJ Klil-Drori","year":"2016","unstructured":"Klil-Drori AJ, Tascilar K, Yin H, Aprikian A, Bitton A, Azoulay L (2016) Androgen deprivation therapy and the incidence of inflammatory bowel disease in patients with prostate cancer. Am J Epidemiol 184(1):15\u201322","journal-title":"Am J Epidemiol"},{"issue":"7","key":"9521_CR30","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.2174\/1570159X15666170313122555","volume":"15","author":"E Wibowo","year":"2017","unstructured":"Wibowo E (2017) Cognitive impacts of estrogen treatment in androgen-deprived males: what needs to be resolved. Curr Neuropharmacol 15(7):1043\u20131055","journal-title":"Curr Neuropharmacol"},{"issue":"10","key":"9521_CR31","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/phar.2168","volume":"38","author":"C Nguyen","year":"2018","unstructured":"Nguyen C, Lairson DR, Swartz MD, Du XL (2018) Risks of major long-term side effects associated with androgen-deprivation therapy in men with prostate cancer. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 38(10):999\u20131009","journal-title":"Pharmacother J Hum Pharmacol Drug Ther"},{"issue":"2","key":"9521_CR32","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41391-022-00536-3","volume":"26","author":"A Kure","year":"2023","unstructured":"Kure A, Tsukimi T, Ishii C, Aw W, Obana N, Nakato G et al (2023) Gut environment changes due to androgen deprivation therapy in patients with prostate cancer. Prostate Cancer Prostatic Dis 26(2):323\u2013330","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"6","key":"9521_CR33","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.eururo.2017.08.013","volume":"73","author":"SJ Egger","year":"2018","unstructured":"Egger SJ, Calopedos RJ, O\u2019Connell DL, Chambers SK, Woo HH, Smith DP (2018) Long-term psychological and quality-of-life effects of active surveillance and watchful waiting after diagnosis of low-risk localised prostate cancer. Eur Urol 73(6):859\u2013867","journal-title":"Eur Urol"},{"issue":"18","key":"9521_CR34","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa1011967","volume":"364","author":"A Axelson","year":"2011","unstructured":"Axelson A, Holmberg L, Ruutu M, H\u00e4ggman M, Andersson SO, Bratell S et al (2011) Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 364(18):1708\u20131717. https:\/\/doi.org\/10.1056\/NEJMoa1011967","journal-title":"N Engl J Med"},{"issue":"3","key":"9521_CR35","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1056\/NEJMoa1113162","volume":"367","author":"TJ Wilt","year":"2012","unstructured":"Wilt TJ, Brawer MK, Jones KM, Barry MJ, Aronson WJ, Fox S et al (2012) Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 367(3):203\u2013213. https:\/\/doi.org\/10.1056\/NEJMoa1113162","journal-title":"N Engl J Med"},{"key":"9521_CR36","doi-asserted-by":"crossref","unstructured":"Metcalfe MJ, Smaldone MC, Lin DW, Aparicio AM, Chapin BF (2017) Role of radical prostatectomy in metastatic prostate cancer: a review. Urol Oncol Semin Orig Investig 35(4):125\u2013134. Elsevier","DOI":"10.1016\/j.urolonc.2017.01.001"},{"issue":"3","key":"9521_CR37","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1177\/1363461508094675","volume":"45","author":"S Kumar","year":"2008","unstructured":"Kumar S, Oakley Browne MA (2008) Usefulness of the construct of social network to explain mental health service utilization by the M\u0101ori population in New Zealand. Transcult Psychiatry 45(3):439\u2013454","journal-title":"Transcult Psychiatry"},{"key":"9521_CR38","unstructured":"Ministry of Health NZ (2018) Principles from Te Ao M\u0101ori \u2013 The M\u0101ori Worldview | He Aronga M\u0101ori ki ng\u0101 M\u0101t\u0101pono. https:\/\/www.mbie.govt.nz\/business-and-employment\/economic-development\/just-transition\/just-transitions-guide\/foundations\/principles-from-te-ao-maori-the-maori-worldview\/"},{"issue":"1","key":"9521_CR39","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jphys.2016.05.018","volume":"63","author":"A Kongsted","year":"2017","unstructured":"Kongsted A, Nielsen AM (2017) Latent class analysis in health research. J Physiother 63(1):55\u201358","journal-title":"J Physiother"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09521-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-09521-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09521-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T14:03:20Z","timestamp":1749477800000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-09521-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["9521"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-09521-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4633058\/v1","asserted-by":"object"}]},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"assertion":[{"value":"25 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"483"}}